UK markets closed

180 Life Sciences Corp. (ATNF)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.0000+0.0300 (+1.52%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.71M
Enterprise value 783.80k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.36
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.04

Trading information

Stock price history

Beta (5Y monthly) 0.44
52-week change 3-90.34%
S&P500 52-week change 322.43%
52-week high 327.9300
52-week low 31.3300
50-day moving average 32.7030
200-day moving average 37.1498

Share statistics

Avg vol (3-month) 3108.76k
Avg vol (10-day) 328.04k
Shares outstanding 5852.77k
Implied shares outstanding 6852.77k
Float 8765.12k
% held by insiders 13.35%
% held by institutions 111.20%
Shares short (15 Apr 2024) 417.08k
Short ratio (15 Apr 2024) 40.16
Short % of float (15 Apr 2024) 42.04%
Short % of shares outstanding (15 Apr 2024) 42.00%
Shares short (prior month 15 Mar 2024) 461.83k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:19
Last split date 328 Feb 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-67.63%
Return on equity (ttm)-355.47%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -13.37M
Net income avi to common (ttm)-19.94M
Diluted EPS (ttm)-52.5900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.98M
Total cash per share (mrq)2.32
Total debt (mrq)1.05M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.72
Book value per share (mrq)-0.24

Cash flow statement

Operating cash flow (ttm)-10.92M
Levered free cash flow (ttm)-6.09M